Literature DB >> 2627421

Two-dimensional color Doppler estimation of the severity of atrioventricular valve regurgitation: important effects of instrument gain setting, pulse repetition frequency, and carrier frequency.

J G Stevenson1.   

Abstract

Literature reports of good correlation between two-dimensional color Doppler and ventriculography for estimation of the severity of atrioventricular valve regurgitation have appeared. Local experience has been variable. The purpose of this study was to evaluate three factors for their effect on two-dimensional color Doppler display of the apparent area of regurgitant flow. The factors studied were instrument gain setting, pulse repetition frequency (PRF), and carrier frequency. Sixteen regurgitant valves were examined with high quality commercial instrumentation from two manufacturers. Electrocardiographic-triggered image gating was used for recording and planimetry of maximal imaged flow area (IFA). Examinations were performed at two gain settings with constant carrier frequency and PRF, at three carrier frequencies (2.5, 3.5, and 5 MHz) at constant gain, and at differing PRF (3.0 to 12 kHz). Reduction in gain setting made little difference in asthetic quality of regurgitant jets, but their areas decreased by 29%. Carrier frequency was found to greatly affect IFA, with each higher carrier frequency giving significantly smaller IFAs. PRF also affected IFA consistently, with progressively smaller IFAs at each higher PRF. There was no useful correlation between IFA of a single jet evaluated on the two instruments at generally similar settings. It is concluded that instrument gain setting, PRF, and carrier frequency each significantly affects the size of IFA within a single instrument and between different instruments. Given the variety of instruments and settings employed within the cardiology community, it is unlikely that even moderately accurate grading of severity of regurgitation based on IFA can be done unless instrument settings are specified and standardized. There is a clear need for annotation of instrument settings during color Doppler examinations and a need for concensus regarding "optimal" settings. Finally, the consistency of reduction in IFA with increasing carrier frequency and PRF within each of the instruments tested suggests investigation of "normalization" of IFA displays.

Entities:  

Mesh:

Year:  1989        PMID: 2627421     DOI: 10.1016/s0894-7317(89)80023-9

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

Review 1.  Developments in cardiovascular ultrasound. Part 3: Cardiac applications.

Authors:  C M Moran; W N McDicken; P R Hoskins; P J Fish
Journal:  Med Biol Eng Comput       Date:  1998-09       Impact factor: 2.602

2.  Accuracy and feasibility of a simplified approach to assess the regurgitant orifice area in patients with mitral regurgitation.

Authors:  Luigi Ascione; Mario De Michele; Maria Accadia; Salvatore Rumolo; Lucia Damiano; Pasquale Guarini; Antonello D'Andrea; Bernardino Tuccillo
Journal:  Int J Cardiovasc Imaging       Date:  2004-04       Impact factor: 2.357

3.  Color Doppler flow mapping of the patent ductus arteriosus in very low birthweight neonates: echocardiographic and clinical findings.

Authors:  D A Roberson; N H Silverman
Journal:  Pediatr Cardiol       Date:  1994 Sep-Oct       Impact factor: 1.655

4.  Doppler echocardiography imaging in detecting multi-valvular lesions: a clinical evaluation in children with acute rheumatic fever.

Authors:  Pushpa Shivaram; Molla Imaduddin Ahmed; Pramod Theetha Kariyanna; Harika Sabbineni; Uma Mahesh R Avula
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

5.  Echocardiographic pattern of rheumatic valvular disease in a contemporary sub-Saharan African pediatric population: an audit of a major cardiac ultrasound unit in Yaounde, Cameroon.

Authors:  Clovis Nkoke; Alain Lekoubou; Anastase Dzudie; Ahmadou Musa Jingi; Samuel Kingue; Alain Menanga; Andre Pascal Kengne
Journal:  BMC Pediatr       Date:  2016-03-21       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.